de Laka-catalogus

nr titel auteur datum
6.07.4.60/36 2016 Medical Isotope Supply ReviewNEA juni 2016
6.07.4.60/29 2017 Medical Isotope Supply Review: Mo/Tc Market Demand and Production Capacity Projection 2017-2022OECD, NEA april 2017
6.07.4.60/11A Silent Crisis. Cancer Treatment in Developing CountriesIAEA 2003
6.07.4.60/14Aanbevelingen nucleaire geneeskundeR.O.Boer, K.S.Wiarda, NVNG 1996
6.07.4.60/35 Alternatives for the production of medical isotopesGreenpeace Netherlands, Profundo, J.W.van Gelder, A.Herder maart 2010
6.07.4.60/07An assessment of "Low-Level" Radioactive Waste Options for Hospitals and Biomedical Research Institutions in New YorkHamilto, Physicians for Social Responsibility juli 1996
6.07.4.60/10Annual Congress of European Association of Nuclear Medicine 23-27 AugustEANM'03 augustus 2003
6.07.4.60/26Co-production of medical radioisotopes in the proposed Accelerator Production of Tritium FacilityLANL december 1998
6.07.4.60/31 Cyclotron Based Production of Technetium-99mIAEA juni 2017
6.07.4.60/06 De betekenis van Petten voor de radiofarmaceutische marktJ.W.van Gelder, Greenpeace september 2000
6.07.4.60/45 Emissions from Fission-Based Medical Isotope Production and their Effects on the International Monitoring SystemTh.W.Bowyer mei 2015
6.07.4.60/46 European Research Reactor Position Paper. Scenario for sustainable Molybdenum-99 production in EuropeCEA, NCBJ, NRG, PALLAS, RCR, SCK•CEN, TUM juni 2018
6.07.4.60/32 Feasibility of Producing Molybdenum-99 on a Small Scale Using Fission of Low Enriched Uranium or Neutron Activation of Natural MolybdenumIAEA januari 2015
6.07.4.60/25 Future Supply of Medical Radioisotopes for the UK Report 2014British Nuclear Medicine Society, Science & Technology Facilities Council november 2014
6.07.4.60/08Het testen van ingekapselde radium bronnen op lekL.B.Beentjes, IRI september 1973
6.07.4.60/50 Innovatie in medische isotopenproductie zonder kernreactorLaka, H.vd Keur februari 2021
6.07.4.60/03Inventarisatie van röntgentoestellen in NL ziekenhuizenDirectie Stralenbescherming 1985
6.07.4.60/43 Isotopic noble gas signatures released from medical isotope production facilities- Simulations and measurementsP.Saey, Th.W.Bowyer, A.Ringbom april 2010
6.07.4.60/05Jaarverslag 1996 Academisch Ziekenhuis LeidenDienst veiligheid Stralenbescherming maart 1997
6.07.4.60/12Krebsbehandlung mit Neutronen fragwürdigKarin Wurzbacher, Umweltinstitut oktober 2003
6.07.4.60/49 Leveringszekerheid voor medische radionucliden - aanvullingen 2020Roobol, Rosenbaum, de Waard, RIVM december 2020
6.07.4.60/15Managing Patient Dose in Digital Radiology: ICRP Publication 93: Vol.34, No.1ICRP 2004
6.07.4.60/42 Marktontwikkeling en leveringszekerheid voor medische radionucliden, aanvullingRoobol, de Waard, RIVM september 2019
6.07.4.60/38 Marktontwikkeling en leveringszekerheid voor medische isotopenRoobol, de Waard, RIVM april 2018
6.07.4.60/41 Marktontwikkeling en leveringszekerheid voor medische radionucliden Roobol, de Waard, RIVM juli 2019
6.07.4.60/44 Maximum reasonable radioxenon releases from medical isotope production facilities and their effect on monitoring nuclear explosionsTh.W.Bowyer, R.kephart, P.W.Eslinger, J.Friese september 2012
6.07.4.60/16 Medical Imaging. A discussion paperA.Sinclair, Medical Devices maart 1998
6.07.4.60/40 Medical isotope production using Lighthouse acceleratorJ.W.Blokker november 2017
6.07.4.60/37 Medical isotopes. Global importance and opportunities for the Netherlands in a European context Nucleair Nederland november 2017
6.07.4.60/04Medical Valley. Nucleaire geneeskunde in de Pettense duinenECN, Mallinckrodt Medical